Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Argus Health
AstraZeneca
QuintilesIMS
US Army

Generated: April 20, 2019

DrugPatentWatch Database Preview

Drug Price Trends for BRIVIACT

« Back to Dashboard

Drug Price Trends for BRIVIACT

Average Pharmacy Cost for BRIVIACT

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
BRIVIACT 100 MG TABLET 50474-0770-09 18.42228 EACH 2019-01-01
BRIVIACT 50 MG TABLET 50474-0570-66 18.26081 EACH 2019-01-01
BRIVIACT 100 MG TABLET 50474-0770-66 18.42228 EACH 2019-01-01
BRIVIACT 50 MG TABLET 50474-0570-09 18.26081 EACH 2019-01-01
BRIVIACT 50 MG TABLET 50474-0570-66 17.06633 EACH 2018-11-21
Drug Name NDC Price/Unit ($) Unit Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
US Department of Justice
Harvard Business School
Chinese Patent Office
UBS
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.